Regulatory Affairs Strategies

Coming Soon | Register Your Interest

Develop and execute a regulatory strategy aligned with your organisation’s goals.

Leave this field blank

By clicking register, you agree to our Privacy Policy

If you would like training for yourself or a group, complete the form above

Enrol before | 11 August to save £400 | 7 September to save £200

Discount has been applied to the price above. VAT, if applicable, will be added.

Course Overview


As a senior regulatory professional, it is critical to align your regulatory knowledge with the wider organisational goals and objectives. This ensures compliance while managing budgets and meeting strict business deadlines.


This course aims to assist you in choosing the optimal registration strategy for your product based on the product type, indication, and your company’s objectives. You will explore your role during the clinical and CMC phases of development and how to prepare for MAA. Additionally, the course will delve into post-approval strategies that concentrate on lifecycle management and worldwide submissions. By the end of this course, you will have the necessary skills and confidence to expedite the approval process of your products, which can translate to significant cost savings.


With the Educo Post Learning Implementation Plan (PLIP) you will have the framework to apply and implement the knowledge acquired in the training, supporting you in your development.

Learn more about how we deliver classroom and live online training.

What is Included in a Live Online Course?


  • Direct access to an expert trainer
  • Interactive and engaging sessions with exercises and discussions
  • Bitesize learning
  • Access to the Educo Life Sciences Training Portal
  • Unlimited access to the recordings for 4 to 5 weeks after the last session
  • Reinforcement session delivered 4 to 5 week after the course (online) providing you with extra time with the trainer
  • A validated certificate of attendance available for you to download

Learn more about how we deliver live online training

Key Learning Objectives


  • Learn how to think strategically throughout the development phases from clinical to manufacturing through to post approval
  • Discover how to implement a global regulatory strategy with a focus on the EU and US procedures
  • Speed up drug registration through skilled utilisation of registration procedures
  • Manage the practical hurdles of submitting MAA/CTD within the deadlines
  • Develop successful strategies specific to your therapeutic product including small molecules, biologics, vaccines, biosimilars and cell & gene therapies
  • Learn best practices when working with Regulators and discover how to negotiate and respond to Regulators’ questions successfully
  • Collect and present key information for the submission dossier to achieve a winning strategy
  • Centralised, Decentralised and MR procedure – Make the most out of the Centralised, Decentralised and MR procedure and get fast approval from Regulators

Learn more about the course by toggling through the tabs below (trainer, agenda, who should attend?)

Post Learning Implementation Plan (PLIP)


  • Access to the Educo Training Portal
  • Submit your needs analysis and objectives for training by completing a simple online form

Action Plan

  • At the end of the training you will create an action plan to help you implement and develop your new skills and knowledge

Reinforcement Session

  • Delivered 3 to 4 weeks after the training
  • It is a 1 hour virtual session enabling the group to reinforce the key learnings from the training and cover and subsequent questions and challenges
Introductory Module 1
FREE to Attend | Live & Recorded

Sign up

TBD | 60 mins | 1:00 PM UK

The role of regulatory affairs

  • An Overview of Regulatory Affairs and European / US Legislation
  • Understanding where we interact during the development cycle
  • Provision of strategy and guidance (how to use guidance)
  • Project and product management – the interface
  • Role within the organisation
Session 1


Drug discovery to first administration in man: The influential role of regulatory affairs
This session will provide insight, with practical examples, on the issues surrounding new drug development, principally as seen from a regulatory perspective.

Clinical Phase I to Phase III – advancing towards the MAA CTD
While developing drugs there are issues, tasks, regulations & procedures that have to be considered. This session will be an opportunity to work through the following challenges:

  • Clinical Development Phase I to III : requirements and applications across the EU
  • Reconciling manufacturing, non-clinical and clinical demands within the regulatory framework and commercial imperatives
  • Guidelines on specific therapeutic areas
Session 2


Problems to be dealt with by the Regulatory Project Leader as the ‘product’ progresses through the later stages of development

  • Identify study and data requirements in order to progress your product through the clinic and towards the market
  • Advise on the clinical development programme
  • Resolve manufacturing, non-clinical and clinical problems as you strive to achieve the earliest filing date for your products MAA / CTD
  • Identify the need for, and timing of, Scientific Advice
  • Modify the Target Drug Profile (TDP) as more data becomes available

A review of key areas

  • Orphan Applications
  • ATMP legislation
  • Generic Criteria
  • Paediatric Legislation
  • Accelerated development processes in EU and US
Session 3


Filing and negotiating approval of the Marketing Authorisation Application (MAA) or Common Technical Document (CTD)
The aim of this session is to identify the main hurdles that regulatory affairs executives face during the MAA / CTD submission. It will take the form of a top-level discussion where best practices will be highlighted by the trainers. Delegates will also be encouraged to put forward their questions and experiences

  • Review of key legislation including the recent Directives and regulations
  • Scientific advice from EMA and national agencies
  • What are the requirements for a successful and readily approvable MAA/CTD?
  • Selecting the registration procedure: MRP, DCP or Centralised Procedure

Working through a MAA / CTD for your product, negotiating with the relevant authorities

  • Prepare the SPC
  • Resolve the objections / consolidated list of questions with the authorities
  • Negotiate final approval
Session 4


Regulatory affairs beyond the MAA

This session will demonstrate strategic approaches to help you manage your regulatory projects from initiation to completion, and assist in your objective to succeed within
your organisation.

  • Regulatory Intelligence and competitive advantage
  • Design a post-approval strategy to give marketing colleagues the ability to claim advantages over competitor products,
  • Optimising your product potential
  • How to be positive and a solution-seeker for your organisation and not a regulatory obstacle
  • Effective utilisation of contract service organisations
  • Regulatory negotiations at senior management level

The lifecycle of products

  • A review of lifecycle management – The Vauban Strategy
  • Maintenance – Change Control Explained – interpreting the definitions
  • Overcome the regulatory hurdles as changes are made to the manufacturing process and the safety profile of the ‘product’
  • Global Role out of dossiers

Andrew Willis is a regulatory and development consultant with 35 years of experience. His management roles have seen him act as global Vice President of Regulatory Affairs and Medical Affairs, creating business and marketing strategies for complex pharmaceutical development projects. Andrew has gained therapeutic experience in areas covering CNS, oncology, urology and pain management.


Experienced with both EU and US applications (NDA, 505 B 2, ANDA, BLA, MAA) for NCEs, generics and line extensions, with particular knowledge of sterile and biotech products. Experience covers multiple applications, scientific advice meetings, Clinical Trial applications (IND and IMPD compilation and submission), orphan drug applications. Significant Experience with novel drug delivery systems has been utilized in all of the above type of applications.


Andrew continues to provide training for all major companies and also a number of EU Member states agencies in CMC, variations and advanced regulatory affairs. More recently for IO Biotech, Andrew was SVP of Quality, Regulatory and CMC sitting on core C-suite providing CTO support activities – overseeing all pharmaceutical development of drug substance and drug products for peptide molecules and ensuring appropriate quality systems are in place.


He currently delivers extensive training courses in Quality By Design, Global Module 3 Requirements, global generic development and Optimizing the Life of Your Products. Specializing in Lifecycle management, creation of new line extensions and development strategies to maximize return on investment.

This course is relevant for anyone working in regulatory affairs at management level or above. It is also ideal for those with 3 to 5 years of experience looking to progress in their regulatory career.

  • Regulatory Affairs Specialist
  • Regional Coordinator
  • Regulatory Affairs Associate
  • Development Pharmacist
  • Pharmacovigilance Manager
  • Regulatory Affairs Attorney
  • Regulatory Affairs Executive
  • Project Managers
  • Regulatory Affairs Manager
  • Strategy Management
  • Regulatory Affairs Officer
  • Quality Manager
Free First Module and Pricing
  • Module 1 is free to attend and is delivered online and is recorded.
  • To enrol onto module 1, please submit your details in the form.
  • Module 1 is recorded so if you are unable to attend, you can catch up ahead of the course start date.
  • There are price tiers for this course. The dates of these are at the located above the course overview.


Frequently asked questions (FAQs)

Could your team benefit from this course?


We can customise this course to meet the requirements of your organisation, delivered as a classroom and/or online course.

For more information you can email us at [email protected] or call +44 (0) 203 111 7357.

Complete our contact form by following the link. Get in touch.

Register For Free Online Session


There are limited spaces on the introductory session. If demand is high you may not be able to attend the live session, however you will be sent the recording. Priority is given to full registrations.

Register For Module 1 | Free

There are limited spaces on module 1. If demand is high you may not be able to attend the live session, however you will be sent the recording. Priority is given to full registrations.

Leave this field blank

By clicking register, you agree to our Privacy Policy



• The training course is delivered either online or in a classroom. Please check which course format you have booked.
• For live online courses, dates and times of modules are subject to change
• Please contact us for the module dates of future deliveries.
• For live online courses, module durations are approximate

15 reviews for

Regulatory Affairs Strategies

Coming Soon | Register Your Interest

  1. Vanessat

    Your site’s position in the search results

  2. Sandrat

    Free analysis of your website

  3. Zarat

  4. Gwent

    I offer mutually beneficial cooperation

  5. Pollyt

    Cool website. There is a suggestion

  6. Mayt

    I really liked your site. Do you mind

  7. Gillt

    Here’s what I can offer for the near future

  8. Roset

    You will definitely like it

  9. Gwent

    Content for your website

  10. Dorothyt

    Web Development Wizards

  11. Tinat

    Can provide a link mass to your website

  12. Mayt

    Your site’s position in the search results

  13. Rebeccat

    Free analysis of your website

  14. Gwent

    SEO Optimizers Team

  15. Stacyt

    I offer mutually beneficial cooperation

Add a review

Your email address will not be published. Required fields are marked *